UT Southwestern Medical Center researchers have identified two lipids that work together with a quintessential protein known ...

Backed by more than 30 peer-reviewed human clinical studies supporting endogenous antioxidant activity, cellular ...

The central question is no longer whether we can innovate, but whether innovation can truly reach patients in time.

Diamyd Medical Announces Finalization Of Database For Interim Analysis In Phase 3 DIAGNODE-3 Trial. STOCKHOLM, Feb. 24, 2026 /PRNewswire/ -- The clinical database has been finalized for the pre-specif ...

LOS ANGELES, CA, UNITED STATES, January 27, 2026 /EINPresswire.com/ — Osato Research Institute today announced that Immun’Âge ®, a fermented papaya preparation ...

BackgroundChronic pain is a widespread and debilitating health issue, characterized by pain that persists beyond normal tissue healing. Increasing evidence ...

The clinical database has been finalized for the pre-specified interim efficacy analysis in Diamyd Medical's ongoing pivotal Phase 3 trial (DIAGNODE-3) evaluating retogatein (rhGAD65) in individuals w ...

Significantly less progression, especially unstable lesions, with relugolix versus leuprol ...

Vice President, Investor Relations at Ascendis Pharma A/S. Joining me on the call today are Jan Moller Mikkelsen, President ...

Pramorelin, also known in scientific literature as a synthetic ghrelin receptor agonist, has emerged as a notable peptide within the broader landscape of endocrine and metabolic research. Its primary ...

A new study explores exercise mimetics as novel therapeutics for depression by triggering muscle-to-brain signals that support mood regulation and resilience.